ロード中...
Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer
PURPOSE: Androgen deprivation therapy may increase diabetes risk. As the benefits of primary androgen deprivation therapy for localized prostate cancer are controversial, and most prostate cancer survivors are of advanced age with comorbidities, it is important to determine if primary androgen depri...
保存先:
| 出版年: | J Urol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4543371/ https://ncbi.nlm.nih.gov/pubmed/25524243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2014.12.027 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|